![Monic Stuart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monic Stuart
Technik-/Wissenschafts-/F&E-Leiter bei
MARKER THERAPEUTICS, INC.
Profil
Dr. Monic Stuart, MD, is a Chief Medical Officer at Cantargia AB and a Chief Medical Officer at Marker Therapeutics, Inc. Dr. Stuart was previously employed as a Vice President-Clinical Development by Geron Corp.
and a Senior Medical Director by Genentech, Inc. He received his undergraduate degree from the University of North Carolina at Chapel Hill, a graduate degree from The Johns Hopkins University and a doctorate degree from the University of North Carolina at Chapel Hill.
Aktive Positionen von Monic Stuart
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.05.2023 |
| CANTARGIA AB | Technik-/Wissenschafts-/F&E-Leiter | 26.10.2026 |
Ehemalige bekannte Positionen von Monic Stuart
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2012 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Ausbildung von Monic Stuart
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
